Boston Scientific Principal Financial Analyst - US Selling Cardiology Group 

United States, Minnesota 

421416091

At Boston Scientific, the Principal Financial Analyst will be responsible for supporting the US Selling function. This highly visible position will also serve as the lead on consolidating total Cardiology Group results, and will work directly with Sales, Divisional, and Finance leadership on a consistent basis. The position requires an outgoing, confidant candidate that can work independently, while building strong relationships with business partners to optimize financial planning, reporting, and analysis. Gathers and publishes financial information related to historical, current, and future performance for management reporting. Performs financial analysis utilizing appropriate financial concepts and recommends appropriate courses of action. Responsibilities also include facilitating month-end close activities, including journal entry preparation and analysis.

Your Responsibilities Include:

• Partner independently with the Selling organization and the Division Finance leaders.
• Develop detailed financial forecasts incorporating historic, trended, and current business information.
• Monitor functional and departmental spending versus budget by highlighting material variances using system generated detail and trend reports.
• Prepare and distribute financial metric packages by gathering and analyzing information related to current performance.
• Present to upper management & business partners and provide guidance on variances and trends.
• Perform financial analysis and recommend alternative courses of action by utilizing appropriate financial tools and creative problem solving.
• Prepare journal entries and assist in month end close as needed to ensure proper accounting at the functional and departmental level.
• Develop and utilize sound financial processes and maintain effective control environment.

Required Qualifications:

• Bachelor’s degree in Finance, Accounting, or related field. MBA or CPA a plus.
• 8+ years’ progressive financial analyst experience in a similar role.
• Excellent technical skills (modeling, macros, Excel, Access, PowerPoint, Hyperion, preferably SAP and VBA)
• Strong financial analysis, communication, organizational and prioritization skills.
• Experience with journal entries and month end close with accounting.
• Ability to work in a dynamic environment, adhere to tight deadlines, attention to detail.
• Must have highly developed customer relationship skills with strong service orientation.
• Holds self-accountable to a performance metric culture building performance excellence.
• Team orientated.

Preferred Qualifications:

• MBA or CPA
  

Compensation fornon-exempt (hourly), non-sales rolesmay also include variable compensation from time to time (e.g., any overtime and shift differential) and annual bonus target (subject to plan eligibility and other requirements).

Compensation forexempt, non-sales rolesmay also include variable compensation, i.e., annual bonus target and long-term incentives (subject to plan eligibility and other requirements).

For MA positions:It is unlawful to require or administer a lie detector test for employment. Violators are subject to criminal penalties and civil liability.

Please be advised that certain US based positions, including without limitation field sales and service positions that call on hospitals and/or health care centers, require acceptable proof of COVID-19 vaccination status. Candidates will be notified during the interview and selection process if the role(s) for which they have applied require proof of vaccination as a condition of employment. Boston Scientific continues to evaluate its policies and protocols regarding the COVID-19 vaccine and will comply with all applicable state and federal law and healthcare credentialing requirements. As employees of the Company, you will be expected to meet the ongoing requirements for your roles, including any new requirements, should the Company’s policies or protocols change with regard to COVID-19 vaccination.